£500K
The University of Nottingham spinout secured the follow-on investment via fund manager Mercia Ventures.
N
Neupulse
Neupulse develops a non-drug wristband therapy to help manage Tourette syndrome.
£3.0MTotal raised
University of Nottingham spinout developing a wearable device to manage the symptoms of Tourette syndrome through nerve stimulation.
Categories
Founders
Barbara Morera
Dr
Barbara is a director and chief research officer at Neupulse, having previously held research roles at the University of Nottingham.
Investors
- £500K
- £2.5MEos AdvisoryLead
Funding history
£2.5M
The seed round was led by Eos Advisory with US investor backing to support regulatory approval across international markets.